FDA Drug Approval, A072079, DIAZEPAM

FDA Drug Approval, A072079, DIAZEPAM

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out

Contents: Summary Basis of Approval

ANDA: 072079
Company: HOSPIRA
Drug Name: DIAZEPAM
Active Ingredients: DIAZEPAM
Strength: 10MG/2ML (5MG/ML)
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 12/20/1988
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AP

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details